Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia
Letter to the Editor
[키워드] antibodies
Antibody titer
anticoagulation
appear
B cell
characteristic
Chest CT
convalescent plasma
COVID-19
COVID-19 virus
cytarabine
discharge
discharged home
female
Frame
ground-glass opacity
Hospitalized
immunosuppressive
Infection
inflammatory markers
intensive care
leukemia
lymphocyte
lymphopenia
nasal
New York City
oxygen
PCR
PCR positivity
polymerase chain
positive
question
raise
Reactivation
receiving
recovered COVID-19 patient
Reinfection
risk
rituximab
SARS-CoV-2
Severe COVID-19 pneumonia
Steroids
Swab
therapy
transfer
Treatment
unlikely
viral reactivation
with COVID-19
[DOI] 10.1186/s13045-020-00968-1 PMC 바로가기 [Article Type] Letter to the Editor
[DOI] 10.1186/s13045-020-00968-1 PMC 바로가기 [Article Type] Letter to the Editor